Ribonucleotide reductase inhibitors as anticancer and antiviral agents.

Ribonucleotide reductase inhibitors as anticancer and antiviral agents. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Ribonucleotide reductase inhibitors as anticancer and antiviral agents. Abstract Text:

Ribonucleotide reductase inhibitors as anticancer and antiviral agents. Publishing Authors By Initials

For similar biochemical phenomena, metabolism, and nutrition: biochemical phenomena: structure-activity relationship research abstracts see: biochemical phenomena, metabolism, and nutrition: biochemical phenomena: structure-activity relationship research

PUBMED ID PMID:

MEDLINE DATE:

Ribonucleotide reductase inhibitors as anticancer and antiviral agents. Journal Published:

PUBLICATION TYPE: Review

Journal: Progress in drug research. Fortschritte der Arznei

VOLUME: 31

Page Numbers: 101-26

Journal Abbreviation:

ISSN: 0071-786X

DAY: 25

MONTH: 02

YEAR: 1987

Ribonucleotide reductase inhibitors as anticancer and antiviral agents. Information

Number of References: 89

LANGUAGE: eng

NlmUniqueID: 1304021

Ribonucleotide reductase inhibitors as anticancer and antiviral agents. Keywords Mesh Terms:

KEYWORDS: Structure-Activity Relationship

MESH TERMS: antagonists & inhibitors

Chemical & Substance for Abstract: Ribonucleotide reductase inhibitors as anticancer and antiviral agents. Information

Substance Name: Ribonucleotide Reductases

Registry Number: EC 1.17.4.-

Grant and Affiliation Information for Ribonucleotide reductase inhibitors as anticancer and antiviral agents.

AFFILIATION:

Country: SWITZERLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Prog Drug Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Ribonucleotide reductase inhibitors as anticancer and antiviral agents Related Publications

• Analysis of the quantitative structure activity relationship of technetium-99m-labeled diaminedithiol (DADT) and propylene-amine-oxime (PAO) brain blood flow analogues.
• Assessment of space radiation effects on solid-state Brillouin phase conjugate mirrors.
• Caco-2 cell permeability vs human gastrointestinal absorption: QSPR analysis.
• Carcinogenicity, mutagenicity and cancer preventing activities of flavonoids: a structure-system-activity relationship (SSAR) analysis.
• Chimeric RNA/DNA oligonucleotide-based gene therapy.
• Construction of a dense SNP map for bovine chromosome 6 to assist the assembly of the bovine genome sequence.
• Design and discovery of new drugs by stepping-up and stepping-down approaches.
• Development of HIV protease inhibitors: a survey.
• Development of HIV protease inhibitors: a survey.
• Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism.
• Effects of furosemide on renal calcium handling.
• Fungal metabolites and Chinese herbal medicine as immunostimulants.
• Glucosamine and chondroitin sulfates in the treatment of osteoarthritis: a survey.
• Immunopharmacological and biochemical bases of Chinese herbal medicine.
• In search of ideal antihypertensive drugs: progress in five decades.
• Incidence of radiation-induced insufficiency fractures of the female pelvis: evaluation with MR imaging.
• Intrapleural streptokinase for the treatment of childhood empyema.
• MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4).
• MOSQUITOES OF TAIWAN: GENUS TOXORHYNCHITES THEOBALD.
• Natural products and their derivatives as cancer chemopreventive agents.
• Outcome of large hemispheric infarcts: an experience of 50 patients in Taiwan.
• Phenotypic Characteristics of Bone in Carbonic Anhydrase II-Deficient Mice.
• Prochlorperazine and chlorpromazine: a comparative clinical trial.
• Purine analogs as CDK enzyme inhibitory agents: a survey and QSAR analysis.
• Regional versus general anesthesia for hip surgery in older patients: does the choice affect patient outcome?
• Ribonucleotide reductase inhibitors as anticancer and antiviral agents.
• Structures, properties and disposition of drugs.
• Unexpected Severe LVH in the Elderly: Consider Fabry's Disease.
• [CARDIOVASCULAR DISEASES IN TAIWAN.]
• [CARDIOVASCULAR DISEASES IN TAIWAN.]